Fliban 100 mg, which contains flibanserin, is not typically used to treat premature ejaculation (PE). Flibanserin is approved for use in premenopausal women with hypoactive sexual desire disorder (HSDD), a condition related to low sexual desire, rather than issues with ejaculation timing. Here’s why it’s not suitable for PE:

Mechanism of Action: Flibanserin works on serotonin and dopamine receptors in the brain to increase sexual desire in women. It does not affect the physiological mechanisms involved in ejaculation, which are different from those affecting sexual desire.

Lack of Efficacy for PE: There is no clinical evidence that Fliban 100 mg helps with premature ejaculation. PE treatments typically involve medications like dapoxetine (a short-acting selective serotonin reuptake inhibitor) or other behavioral techniques that target ejaculatory control.

Potential Side Effects: Fliban 100 mg may cause side effects like dizziness, fatigue, nausea, and low blood pressure, especially when combined with alcohol. Using it without a specific need can increase the risk of these side effects without any benefits for PE.

If you’re seeking treatment for premature ejaculation, discussing options like dapoxetine, behavioral therapy, or other proven methods with your healthcare provider is recommended. These treatments are specifically designed to help manage PE safely and effectively.